U.S. Vitrification Market – By Product Type (Devices [Open System, Closed System], Kits, Reagents), Specimen (Embryos, Oocytes, Sperms), End-user (IVF Clinics, Biobanks), Zone – Forecast 2024 ­ 2032

U.S. Vitrification Market – By Product Type (Devices [Open System, Closed System], Kits, Reagents), Specimen (Embryos, Oocytes, Sperms), End-user (IVF Clinics, Biobanks), Zone – Forecast 2024 ­ 2032

U.S. Vitrification Market Size

U.S. Vitrification Market size was valued at USD 3.4 billion in 2023 growing at a CAGR of 9.8% from 2024 to 2024. Vitrification is a rapid freezing technique utilized in cryopreservation that transforms a liquid into a glass-like solid without forming ice crystals. This method is beneficial for preserving biological specimens such as embryos, oocytes, and stem cells, as it reduces cellular damage during the freezing and thawing processes. By maintaining the integrity and viability of preserved materials, vitrification is a favoured technique in fields of reproductive medicine and biotechnology.

To get key market trends

  Download Free Sample

The market is experiencing significant growth driven by the increasing infertility rates that surged the demand for advanced fertility treatments. According to the CDC, approximately 10% of U.S. women aged 15 to 44 experience difficulties in conceiving. This trend boosts the need for fertility preservation services. Therefore, IVF technique including assisted reproductive technology (ART) involving egg extraction, fertilization in labs, and embryo transfers has doubled in the past decade, contributing to about 2.3% of annual U.S. births in 2021. The increasing demand for infertility treatments features the importance of vitrification, enhancing the IVF success rates and driving market growth in fertility clinics. Furthermore, the increasing emphasis on biobanking and regenerative medicine contributes to market growth, with vitrification playing a critical role in the extended storage of biological samples.
 

What are the growth opportunities in this market?

 Download Free Sample

U.S. Vitrification Market Trends

The increasing demand for fertility treatments has driven more people to opt for ART. As more individuals and couples seek options such as IVF and egg freezing, the need for advanced preservation methods has surged in demand. Vitrification, a rapid freezing technique, is crucial in enhancing the success rates of ART procedures, thereby fuelling market growth. This trend reflects the broader acceptance and reliance on fertility treatments in the U.S.

• For instance, in April 2024, the Society for Assisted Reproductive Technology reported a 2.5% increase in U.S births from IVF, with 91,771 babies born in 2022 compared to 89,208 in 2021. The total number of IVF cycles performed at Society for Assisted Reproductive Technology (SART) member clinics grew by over 6% to 389,993 in 2022, reflecting rising demand for IVF services despite legal challenges. Similarly, egg-freezing cycles also increased to 29,803, up from 24,560 in 2021, indicating a growing interest in ART options. Thus, this growth in ART procedures has driven the expansion of the market, which is crucial for preserving gametes and embryos used in these treatments.

U.S. Vitrification Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

Based on the product type, the market is classified into devices, kits, and reagents & consumables. The devices segment dominated the market with a revenue of USD 1.5 billion in 2023.

• The dominance of the vitrification devices segment in the U.S. market is attributed to its pivotal role in rapidly freezing biological specimens for preservation. Vitrification devices are essential for maintaining the viability of embryos, oocytes, and sperm during storage for ART and other biomedical applications.
• In addition, the increasing demand for advanced fertility treatments coupled with expanding applications in biobanking and regenerative medicine propels the growth.
• Furthermore, the technological advancements improving success rates in ART procedures further bolster the adoption of vitrification devices, underscoring their critical position in the market.

Learn more about the key segments shaping this market

 Download Free Sample

Based on the specimen, the U.S. vitrification market is classified into embryos, oocytes, and sperms. The oocytes segment dominated the market with a market share of 48.6% in 2023.

• Oocytes, or eggs are crucial biological specimens used in IVF and egg-freezing procedures, which are increasingly sought after by individuals and couples facing infertility challenges. Thus, the segment's dominance reflects the rising awareness and acceptance of these technologies, driven by factors such as delayed childbearing and increasing infertility rates.
• Furthermore, the sperms segment is projected to witness the fastest CAGR of 9.9% driven by advancements in 3D printing that are set to revolutionize freezing device manufacturing. For instance, an MDPI article from August 2021 showcased a 3D-printed vitrification device for Cryo-Vials (VDCV), designed for handling small sperm volumes. This signified the increasing sophistication and awareness surrounding sperm freezing, thereby positioning the segment for substantial growth within the market.

Based on the end-user, the U.S. vitrification market is classified into in vitro fertilization clinics and biobanks. The in vitro fertilization clinics segment dominated the market with the highest market share in 2023 with a CAGR of 9.5%.

• IVF clinics have solidified their dominance due to escalating demand for ART services, spurred by rising infertility rates and advancements in reproductive medicine. Also, growth drivers include increasing infertility rates, delayed parenthood, and greater acceptance of fertility treatments signifying IVF growth in recent years.
• Further, advances such as preimplantation genetic testing and egg freezing have further fuelled market expansion. 

Looking for region specific data?

 Download Free Sample

In 2023, the Northeast zone held the highest market revenue in the U.S. vitrification market and is expected to dominate with a CAGR of 9.2% throughout the forecast period.

• The Northeast zone, particularly states such as New York, Massachusetts, Pennsylvania, and New Jersey has a significant presence of advanced medical facilities and research centers focused on reproductive health. This concentration fosters a robust demand for advanced fertility preservation technologies.
• In addition, the Northeast region is home to numerous biotech companies and leading academic institutions that contribute to the development and advancement of vitrification technologies, thereby expanding the growth.
• Furthermore, the supportive regulatory framework for fertility treatments and ART encourages the adoption of vitrification techniques, thereby strengthening the position in the competitive landscape.

New York state held a substantial market size of USD 223 million in 2023.

• The state’s prominence in the market is highlighted by its concentration of leading medical institutions, fertility clinics, and innovative biotech companies. Also, the state's supportive regulatory environment, reimbursement policies, and robust healthcare infrastructure further bolster its position, attracting a high volume of patients seeking advanced reproductive services.
• For instance, The NYS Department of Health supports high-volume infertility service providers such as Genesis Fertility & Reproductive Medicine and Reproductive Medicine Associates of New York (RMA of NY) through the Infertility Demonstration Program (IRP). The services include up to two complete IVF cycles per patient, encompassing medications, monitoring, lab tests, egg retrieval, fertilization, ICSI, and embryo transfer. The program's current term is from October 1, 2022, to September 30, 2024, subject to state funding availability for continuation. Therefore, favorable reimbursement policies aim to provide supportive treatment options, thereby expanding the U.S. market.

U.S. Vitrification Market Share

The U.S. vitrification industry is characterized by a diverse range of companies offering advanced freezing and preservation technologies for biological specimens such as embryos, oocytes, and sperm. The key competitive factors include technological innovation in vitrification devices, efficacy of cryopreservation techniques, and geographic market reach. Also, strategic partnerships with fertility clinics and research institutions enhance market penetration.

U.S. Vitrification Market Companies

Prominent players operating in the U.S. vitrification industry are as mentioned below

• Biotech, Inc.
• CooperSurgical Fertility Company
• FERTIPRO NV
• FUJIFILM Irvine Scientific
• Genea BIOMEDX
• IMV Technologies Group (Cryo Bio System)
• Kitazato Corporation.
• MFC Global 
• MINITÜB GMBH
• NidaCon International AB
• Optimas 
• Shenzhen VitaVitro Biotech
• Vitrolife 

U.S. Vitrification Industry News

• In October 2023, Cellipont Bioservices and Evia Bio entered into a strategic partnership to establish the Cryopreservation Excellence Center (CryoX) at Cellipont Bioservices' cGMP cell therapy manufacturing site in Texas. CryoX aims to bring together cryopreservation experts, technologies, and organizations to enhance therapeutic "cold chain" practices and standards. This initiative aimed to expand advancement in cryopreservation techniques and promote excellence in therapeutic storage solutions.
• In July 2023, Ivy Fertility expanded its partnership with TMRW Life Sciences to automate its IVF lab using TMRW's innovative platform for safe storage of frozen eggs and embryos. Previously available at two clinics, TMRW's technology will now be implemented across all 13 Ivy Fertility clinics in the U.S. This expansion aimed to enhance IVF procedures and drive demand for vitrification techniques in the market.

The U.S. vitrification market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments

Click here to Buy Section of this Report

Market, By Product Type

• Devices
  • Open system
  • Closed system
• Kits
• Reagents & consumables

Market, By Specimen

• Embryos
• Oocytes
• Sperms

Market, By End-user

• In vitro fertilization clinics
• Biobanks

The above information is provided for the following zone and states

• Northeast
  • Connecticut
  • Maine
  • Massachusetts
  • New Hampshire
  • Rhode Island
  • Vermont
  • New Jersey
  • New York
  • Pennsylvania 
• East North Central
  • Wisconsin
  • Michigan
  • Illinois
  • Indiana
  • Ohio
•  West North Central
  • North Dakota
  • South Dakota
  • Nebraska
  • Kansas
  • Minnesota
  • Iowa
  • Missouri
• South Atlantic  
  • Delaware
  • Maryland
  • Virginia
  • West Virginia
  • North Carolina
  • South Carolina
  • Georgia
  • Florida
• East South Central          
  • Kentucky
  • Tennessee
  • Mississippi
  • Alabama
• West South Central        
  • Oklahoma
  • Texas
  • Arkansas
  • Louisiana
• Mountain States             
  • Idaho
  • Montana
  • Wyoming
  • Nevada
  • Utah
  • Colorado
  • Arizona
  • New Mexico
• Pacific Central  
  • California
  • Alaska
  • Hawaii
  • Oregon
  • Washington